C. Ballard

发表

A Randomized Controlled Trial of a Digital Adaptation of the WHELD Person-Centered Nursing Home Training Program.

A. Corbett, Z. Khan, J. McDermid, 2022, Journal of the American Medical Directors Association.

Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits

F. Happé, D. Aarsland, A. Corbett, 2022, Journal of Autism and Developmental Disorders.

A. Corbett, J. Geissler, G. Hickey, 2022, Communications Medicine.

Impact of Psychotic Symptoms and Concurrent Neuropsychiatric Symptoms on the Quality of Life of People With Dementia Living in Nursing Homes.

L. Clare, Z. Khan, J. Fossey, 2022, Journal of the American Medical Directors Association.

Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial

G. Livingston, Sube Banerjee, I. Leroi, 2022, International Psychogeriatrics.

Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85

J. Gallacher, N. Mutrie, Anne E. Ferrey, 2022, Frontiers in Public Health.

Healthcare utilisation, physical activity and mental health during COVID-19 lockdown: an interrupted time-series analysis of older adults in England

A. Corbett, C. Hulme, Siobhan O'Dwyer, 2022, European Journal of Ageing.

The cognitive profile of middle‐aged and older adults with high vs. low autistic traits

F. Happé, D. Aarsland, H. Brooker, 2022, Autism research : official journal of the International Society for Autism Research.

Characterization of Depressive Symptoms in Dementia and Examination of Possible Risk Factors

M. Lawton, L. Sinclair, J. Palmer, 2023, Journal of Alzheimer's disease reports.

Depth of anaesthesia optimisation and postoperative cognitive dysfunction.

G. Kunst, D. Green, C. Ballard, 2015, British journal of anaesthesia.

Cost-Effectiveness of an Online Intervention for Caregivers of People Living With Dementia.

Catherine Henderson, J. Fossey, M. Knapp, 2022, Journal of the American Medical Directors Association.

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

B. Zinman, C. Torp‐Pedersen, T. Gerds, 2022, Alzheimer's & dementia.

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings

D. Aarsland, A. Corbett, E. Moniz-Cook, 2023, International journal of geriatric psychiatry.

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program

P. Tariot, J. Molinuevo, A. Atri, 2018, Alzheimer's Research & Therapy.

PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trial

L. Shepstone, A. MacLullich, F. Poland, 2022, BMJ Open.

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022

J. Cummings, D. Aarsland, K. Poston, 2023, Neurology and Therapy.

Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

Alan J. Thomas, G. Livingston, Sube Banerjee, 2021, The Lancet.

Neurotoxicity of general anaesthesia is hypothetical Reply from the

Uk, D. Green, C. Ballard, 2022 .

Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study.

D. Aarsland, H. Brooker, A. Corbett, 2023, Journal of neurotrauma.

The following abstracts were presented at the Annual Spring Meeting of the Association of Cardiothoracic Anaesthetists (ACTA) in Cambridge, June 2013

J. Aron, K. Salaunkey, P. Townsend, 2013 .

A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientiﬁc evidence

S. Zuidema, R. Koopmans, G. Selbaek, 2015 .

Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocol

G. Livingston, J. Reeve, A. Aryankhesal, 2022, BMJ Open.

Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses

Abdul Rasheed Mohammed, R. Nirogi, J. Cummings, 2022, International journal of geriatric psychiatry.

Development and assessment of a brief screening tool for psychosis in dementia

B. Dickerson, A. Atri, Z. Ismail, 2021, Alzheimer's & dementia.

Intraoperative Optimization of Both Depth of Anesthesia and Cerebral Oxygenation in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery-A Randomized Controlled Pilot Trial.

G. Kunst, K. Salaunkey, D. Green, 2019, Journal of cardiothoracic and vascular anesthesia.

Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: A cluster randomized trial

D. Aarsland, G. Selbæk, C. Ballard, 2014, European journal of pain.

Physical and mental health conditions account for variability in awareness of age-related changes

H. Brooker, A. Corbett, A. Hampshire, 2023, Frontiers in psychiatry.

Cost-effectiveness of Dementia Mapping in care home settings – Evaluation of a randomised controlled trial

D. Meads, C. Surr, Louise, 2021 .

Online assessment of risk factors for dementia and cognitive function in healthy adults

R. Stenton, K. Wesnes, C. Ballard, 2018, International journal of geriatric psychiatry.